Sanofi, Regeneron Expand Testing of Potential Coronavirus Treatment Sanofi, Regeneron Expand Testing of Potential Coronavirus Treatment
Sanofi and Regeneron Pharmaceuticals Inc have expanded a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: Arthritis | Clinical Trials | Coronavirus | COVID-19 | Infectious Diseases | Intensive Care | Rheumatoid Arthritis | Rheumatology | USA Health